• Je něco špatně v tomto záznamu ?

Role of combined prenatal and postnatal paracetamol exposure on asthma development: the Czech ELSPAC study

P. Piler, J. Švancara, L. Kukla, H. Pikhart,

. 2018 ; 72 (4) : 349-355. [pub] 20180125

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc19035432
E-zdroje Online Plný text

NLK ProQuest Central od 1979-06-01 do Před 6 měsíci
Nursing & Allied Health Database (ProQuest) od 1979-06-01 do Před 6 měsíci
Health & Medicine (ProQuest) od 1979-06-01 do Před 6 měsíci
Psychology Database (ProQuest) od 1979-06-01 do Před 6 měsíci
Public Health Database (ProQuest) od 1979-06-01 do Před 6 měsíci

BACKGROUND: Prenatal and postnatal paracetamol exposure has been previously associated with asthma development in childhood in Western populations. We explore the association between prenatal and postnatal paracetamol exposure and asthma development in a Central European sample of Czech children, suggesting possible additive effect of the both exposures. Furthermore, since aspirin had been used more widely during study data collection in Central Europe, we also compared asthma development for those exposed to paracetamol and aspirin. METHODS: We used data from 3329 children born in the 1990s as members of the prospective Czech European Longitudinal Study of Pregnancy and Childhood. Data about prenatal and postnatal paracetamol and aspirin exposure, and potential covariates were obtained from questionnaires completed by mothers. Data about incident asthma were obtained from paediatrician health records. RESULTS: 60.9% of children received paracetamol only postnatally, 1.5% only prenatally and 4.9% of children were exposed both during pregnancy and infancy. Prevalence of asthma in following population was 5% at 11 years. Being exposed to paracetamol both in prenatal and postnatal period was associated with asthma development (unadjusted OR 1.98, 95% CI 1.02 to 3.87). Being exposed only in the postnatal period was also significantly associated with increased risk of asthma. No association between prenatal exposure only and outcome was found. A higher but non-significant risk of asthma was observed for those whose mothers used paracetamol during pregnancy compared with those who used aspirin. CONCLUSIONS: The main findings of this prospective birth cohort study add to previous observations linking prenatal and early postnatal paracetamol exposure to asthma development. However, the magnitude of effect is relatively modest, and therefore, we recommend paracetamol to remain the analgesic and antipyretic of choice throughout pregnancy and early childhood.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc19035432
003      
CZ-PrNML
005      
20191014105618.0
007      
ta
008      
191007s2018 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1136/jech-2017-209960 $2 doi
035    __
$a (PubMed)29371328
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Piler, Pavel $u Research Centre for Toxic Compounds in the Environment (RECETOX), Faculty of Science, Masaryk University, Brno, Czech Republic.
245    10
$a Role of combined prenatal and postnatal paracetamol exposure on asthma development: the Czech ELSPAC study / $c P. Piler, J. Švancara, L. Kukla, H. Pikhart,
520    9_
$a BACKGROUND: Prenatal and postnatal paracetamol exposure has been previously associated with asthma development in childhood in Western populations. We explore the association between prenatal and postnatal paracetamol exposure and asthma development in a Central European sample of Czech children, suggesting possible additive effect of the both exposures. Furthermore, since aspirin had been used more widely during study data collection in Central Europe, we also compared asthma development for those exposed to paracetamol and aspirin. METHODS: We used data from 3329 children born in the 1990s as members of the prospective Czech European Longitudinal Study of Pregnancy and Childhood. Data about prenatal and postnatal paracetamol and aspirin exposure, and potential covariates were obtained from questionnaires completed by mothers. Data about incident asthma were obtained from paediatrician health records. RESULTS: 60.9% of children received paracetamol only postnatally, 1.5% only prenatally and 4.9% of children were exposed both during pregnancy and infancy. Prevalence of asthma in following population was 5% at 11 years. Being exposed to paracetamol both in prenatal and postnatal period was associated with asthma development (unadjusted OR 1.98, 95% CI 1.02 to 3.87). Being exposed only in the postnatal period was also significantly associated with increased risk of asthma. No association between prenatal exposure only and outcome was found. A higher but non-significant risk of asthma was observed for those whose mothers used paracetamol during pregnancy compared with those who used aspirin. CONCLUSIONS: The main findings of this prospective birth cohort study add to previous observations linking prenatal and early postnatal paracetamol exposure to asthma development. However, the magnitude of effect is relatively modest, and therefore, we recommend paracetamol to remain the analgesic and antipyretic of choice throughout pregnancy and early childhood.
650    _2
$a paracetamol $x škodlivé účinky $x terapeutické užití $7 D000082
650    _2
$a neopioidní analgetika $x škodlivé účinky $x terapeutické užití $7 D018712
650    _2
$a bronchiální astma $x epidemiologie $7 D001249
650    _2
$a předškolní dítě $7 D002675
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a kojenec $7 D007223
650    _2
$a longitudinální studie $7 D008137
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a matky $7 D009035
650    _2
$a postnatální péče $7 D011181
650    _2
$a těhotenství $7 D011247
650    _2
$a prenatální péče $7 D011295
650    _2
$a zpožděný efekt prenatální expozice $x epidemiologie $7 D011297
650    _2
$a respirační zvuky $x etiologie $7 D012135
650    _2
$a rizikové faktory $7 D012307
651    _2
$a Česká republika $x epidemiologie $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Švancara, Jan $u Research Centre for Toxic Compounds in the Environment (RECETOX), Faculty of Science, Masaryk University, Brno, Czech Republic. Institute of Biostatistics and Analyses, Faculty of Medicine and Faculty of Science, Masaryk University, Brno, Czech Republic.
700    1_
$a Kukla, Lubomír $u Research Centre for Toxic Compounds in the Environment (RECETOX), Faculty of Science, Masaryk University, Brno, Czech Republic.
700    1_
$a Pikhart, Hynek $u Research Centre for Toxic Compounds in the Environment (RECETOX), Faculty of Science, Masaryk University, Brno, Czech Republic. Department of Epidemiology and Public Health, University College London, London, UK.
773    0_
$w MED00002661 $t Journal of epidemiology and community health $x 1470-2738 $g Roč. 72, č. 4 (2018), s. 349-355
856    41
$u https://pubmed.ncbi.nlm.nih.gov/29371328 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20191007 $b ABA008
991    __
$a 20191014110042 $b ABA008
999    __
$a ok $b bmc $g 1452092 $s 1073982
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2018 $b 72 $c 4 $d 349-355 $e 20180125 $i 1470-2738 $m Journal of epidemiology and community health $n J Epidemiol Community Health $x MED00002661
LZP    __
$a Pubmed-20191007

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...